![holding rapt holding rapt](https://static.wixstatic.com/media/858956_805428579dcd4aebbe1267cf73522115~mv2_d_3264_2448_s_4_2.jpg)
(NASDAQ: IMUX) jumped 19.2% to settle at $11.49. (NASDAQ: BFRI) gained 22% to close at $6.26. Olink said it sees Q4 sales of $43.2 million to $43.7 million and expects FY21 sales of $94.5 million to $95 million.
![holding rapt holding rapt](http://impactofrapmusiconyouths.weebly.com/uploads/2/4/4/9/24490444/819344615.jpg)
#HOLDING RAPT FULL#
(NASDAQ: BCRX) jumped 27.9% to close at $14.78 after the company announced preliminary, unaudited ORLADEYO revenue for Q4 and FY21 and provided new guidance for full year 2022 ORLADEYO net revenue and expected peak ORLADEYO sales. (NASDAQ: RXST) gained 28.2% to settle at $11.50 after the company late Sunday issued preliminary Q4 and FY21 guidance above estimates. Reliance Global Group, last month, announced pricing of $20.0 million private placement with institutional investors. (NASDAQ: RELI) climbed 28.9% to close at $7.86. Molecular Partners AG (NASDAQ: MOLN) surged 30.5% to settle at $21.50 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
#HOLDING RAPT SOFTWARE#
(NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion. Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.